Our product development team continues its strong research orientation in formulation development to transform VPL into a truly international one. As a generic drug company we have given top priority in building and strengthening capabilities to excel in formulating technologically complex products in order to create strong differentiation. Our R&D team develops a wide range of generic products including difficult to copy formulations in defined specialty areas. We have successfully developed multi-layer tablet, sustained release formulation, dispersible tablet, prefilled syringes, sterile ophthalmics etc. We have made a number of submissions with EU and US regulatory authorities while there is a growing pipeline of submissions for the regulated markets. Our research and development activities are closely focused on market needs and driven by technological progress. A new, state-of-the-art research lab is being set up to facilitate the development of innovative and difficult products with a focus to create unique market opportunities.